Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑Sol...
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial
About this item
Full title
Author / Creator
Trøseid, Marius , Arribas, José R , Assoumou, Lambert , Holten, Aleksander Rygh , Poissy, Julien , Terzic, Vida , Mazzaferri, Fulvia , Baño, Jesús Rodríguez , Eustace, Joe , Hites, Maya , Joannidis, Michael , Paiva, José-Artur , Reuter, Jean , Püntmann, Isabel , Patrick-Brown, Thale Dawn , Westerheim, Elin , Nezvalova-Henriksen, Katerina , Beniguel, Lydie , Dahl, Tuva Børresdatter , Bouscambert, Maude , Halanova, Monika , Péterfi, Zoltán , Tsiodras, Sotirios , Rezek, Michael , Briel, Matthias , Ünal, Serhat , Schlegel, Martin , Ader, Florence , Lacombe, Karine , Amdal, Cecilie Delphin , Rodrigues, Serge , Tonby, Kristian , Gaudet, Alexandre , Heggelund, Lars , Mootien, Joy , Johannessen, Asgeir , Møller, Jannicke Horjen , Pollan, Beatriz Diaz , Tveita, Anders Aune , Kildal, Anders Benjamin , Richard, Jean-Christophe , Dalgard, Olav , Simensen, Victoria Charlotte , Baldé, Aliou , de Gastines, Lucie , del Álamo, Marta , Aydin, Burç , Lund-Johansen, Fridtjof , Trabaud, Mary-Anne , Diallo, Alpha , Halvorsen, Bente , Røttingen, John-Arne , Tacconelli, Evelina , Yazdanpanah, Yazdan , Olsen, Inge Christoffer , Costagliola, Dominique and Study Group, EU-SolidAct
Journal title
Language
Norwegian
Formats
More information
Scope and Contents
Contents
Background
Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants.
Methods
Bari-SolidAct is a phase-3, multicentre, randomised, double-blind, placebo-controlled trial, enrolling participants from June 3, 20...
Alternative Titles
Full title
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial
Authors, Artists and Contributors
Author / Creator
Arribas, José R
Assoumou, Lambert
Holten, Aleksander Rygh
Poissy, Julien
Terzic, Vida
Mazzaferri, Fulvia
Baño, Jesús Rodríguez
Eustace, Joe
Hites, Maya
Joannidis, Michael
Paiva, José-Artur
Reuter, Jean
Püntmann, Isabel
Patrick-Brown, Thale Dawn
Westerheim, Elin
Nezvalova-Henriksen, Katerina
Beniguel, Lydie
Dahl, Tuva Børresdatter
Bouscambert, Maude
Halanova, Monika
Péterfi, Zoltán
Tsiodras, Sotirios
Rezek, Michael
Briel, Matthias
Ünal, Serhat
Schlegel, Martin
Ader, Florence
Lacombe, Karine
Amdal, Cecilie Delphin
Rodrigues, Serge
Tonby, Kristian
Gaudet, Alexandre
Heggelund, Lars
Mootien, Joy
Johannessen, Asgeir
Møller, Jannicke Horjen
Pollan, Beatriz Diaz
Tveita, Anders Aune
Kildal, Anders Benjamin
Richard, Jean-Christophe
Dalgard, Olav
Simensen, Victoria Charlotte
Baldé, Aliou
de Gastines, Lucie
del Álamo, Marta
Aydin, Burç
Lund-Johansen, Fridtjof
Trabaud, Mary-Anne
Diallo, Alpha
Halvorsen, Bente
Røttingen, John-Arne
Tacconelli, Evelina
Yazdanpanah, Yazdan
Olsen, Inge Christoffer
Costagliola, Dominique
Study Group, EU-SolidAct
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_cristin_nora_10852_98801
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_cristin_nora_10852_98801
Other Identifiers
ISSN
1364-8535
E-ISSN
1466-609X
